Post-operative Residual Voiding Volume Following Bulking and Vaginal Prolapse Surgery and Impact on In-hospital Stay (POUR)
Surgery-Complications
About this trial
This is an interventional treatment trial for Surgery-Complications focused on measuring surgery, complication
Eligibility Criteria
Inclusion Criteria: • Women who undergo anterior, posterior or vaginal vault prolapse surgery or bulking surgery at the departments of obstetric and gynecology, OUH. Women who have the catheter removed at the operating room. Women >18 years old. Exclusion Criteria: Any surgery performed by due to malignancy Previous cancer in the pelvic area Previous radiation therapy in the pelvic area Previous surgery in the pelvic area Patients not understanding Danish Patients with mental or similar illness Patients with multiple sclerosis or diabetes type 1 Patients with late KAD removal based on per operative assessment
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
group B
Group A
Group B is the intervention group with minimalistic voiding trial. The patients in this group need to have one spontaneous voiding before discharge with the sensation of normal voiding, meaning there is no measurement of the voiding volume or residual volume.
Group A is the control group and presents the current procedures with strict voiding trial. The bladder is scanned before voiding to determine the bladder volume, and the voiding volume is measured. If the voiding volume is >150 ml and the residual volume is <200 ml, the patient can be discharged. If no acceptable residual volume is reached, the patient will be instructed in intermittent catheterization